Paul Seltman, Smith & Nephew - Co-Chair
This Committee addresses the issues associated with the major percentage of US GDP devoted to health care, and assesses the impact of any newly enacted health care reform law on businesses and individuals. The Committee provides information related to the expansion of insurance, the creation of new markets and government approaches to the delivery of services and products, and the potential impact on innovation. In addition to health care issues, the committee's focus includes the growing and dynamic field of bioscience technology.
AstraZeneca and Oxford University's Partnership on the Covid-19 Vaccine - View Program Video Here